NewGenIvf Group Ltd (NIVF) Insider Share Increase via Option Exercise

On June 8, 2026, Wing Fung Alfred Siu (Chairman and CEO) and his spouse, Hei Yue Tina Fong (Director and CMO), filed an amendment to their Schedule 13D for NewGenIvf Group Ltd (NIVF). The filing reports the acquisition of 113,702 Class B ordinary shares resulting from the exercise of share options granted under the Issuer's 2024 Share Incentive Plan. On May 4, 2026, each reporting person was granted 56,851 options for no consideration. Following a Board resolution on May 26, 2026, to accelerate the options, the reporting persons exercised them on June 4, 2026, at an exercise price of $0.0001 per share. The exercise was settled via a debit to their directors' current accounts. Following these transactions, the reporting persons collectively beneficially own 113,771 Class B ordinary shares, representing 2.8% of the total issued and outstanding shares (calculated against 3,912,518 Class A and 113,771 Class B shares). The reporting persons share voting and dispositive power over these securities and intend to retain them to maintain control of the Issuer.